NEW YORK, Jan. 28, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
